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ZebraﬁshDuring early zebraﬁsh embryogenesis, spontaneous tail contractions represent the ﬁrst sign of locomotion and
result from innervation of primary motoneuron axons to target axial muscles. Based on a high-content screen,
we previously demonstrated that exposure of zebraﬁsh embryos to abamectin – an avermectin insecticide –
from 5–25 hours post-fertilization (hpf) abolished spontaneous activity in the absence of effects on survival
and gross morphology. Therefore, the objective of this study was to begin investigating the mechanism of
abamectin-induced hypoactivity in zebraﬁsh. Similar to 384-well plates, static exposure of embryos to abamectin
from 5–25 hpf in glass beakers resulted in elimination of activity at low micromolar concentrations. However,
abamectin did not affect neurite outgrowth from spinal motoneurons and, compared with exposure from
5–25 hpf, embryos were equally susceptible to abamectin-induced hypoactivity when exposures were initiated
at 10 and 23 hpf. Moreover, immersion of abamectin-exposed embryos in clean water resulted in complete
recovery of spontaneous activity relative to vehicle controls, suggesting that abamectin reversibly activated
ligand-gated chloride channels and inhibited neurotransmission. To test this hypothesis, we pretreated embryos
to vehicle or non-toxic concentrations of ﬁpronil or endosulfan – two insecticides that antagonize the
γ-aminobutyric acid (GABA) receptor – from 5–23 hpf, and then exposed embryos to vehicle or abamectin
from 23–25 hpf. Interestingly, activity levels within abamectin-exposed embryos pretreated with either
antagonist were similar to embryos exposed to vehicle alone. Using quantitative PCR and phylogenetic analyses,
we then conﬁrmed thepresence of GABA receptorα1 andβ2 subunits at 5, 10, and 23hpf, and demonstrated that
zebraﬁsh GABA receptor subunits are homologous to mammalian GABA receptor subunits. Overall, our data
collectively suggest that abamectin induces rapid and reversible hypoactivity within early zebraﬁsh embryos,
an effect that may be mediated through the GABA receptor.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Avermectins are naturally occurring 16-membered macrocyclic
lactones produced as fermentation products by a soil-dwelling
actinomycete bacterium (Streptomyces avermitilis). Isolated in the
1970's from a soil sample collected within Japan, these compounds
have potent antihelminthic and antiparasitic properties (Rugg et al.,
2010), with a unique ability to act as “endectocides” on both ecto- and
endoparasites (Omura and Crump, 2004). Although the mechanism of
action is still not fully understood, avermectins are thought to induce
neurotoxicity within invertebrates and vertebrates by direct activation
or potentiation of glutamate- and/or γ-aminobutyric acid (GABA)-
gated chloride channels, resulting in paralysis and eventually death
(Bloomquist, 1996; Sanchez-Bayo, 2012). Despite uncertainties about
the speciﬁc mechanism of action, the broad-spectrum activity of1 803 777 3391.
. This is an open access article underavermectins has led to widespread use for animal health and crop
protection over the last 30 years.
Avermectins consist of four related compounds (A1, A2, B1, B2), each
containing a major (A1a, A2a, B1a, B2a) and minor (A1b, A2b, B1b, B2b)
component (Clark et al., 1995; Jansson et al., 1996). As a synthetic
derivative of avermectin B1 (or abamectin), ivermectin was the ﬁrst
commercially available avermectin introduced in 1981 as an antipara-
sitic in domestic animals. In addition to veterinary applications,
ivermectin is also used to treat onchocerciasis in humans, a disease
commonly known as River Blindness (Campbell, 2012). In 1985,
abamectin (80% B1a:20% B1b) was introduced as an agricultural insecti-
cide and miticide in addition to its use as a veterinary antiparasitic
drug. As a result, abamectin is now registered worldwide for insect
andmite control on crops such as citrus, nuts, ornamental plants, cotton,
vegetables, strawberries, and grapes, as well as for control of ﬁre ants
(Dybas, 1989). From 1992–2005, only about 10,000 lb of abamectin
per year was used in the United States, with the majority of use on
orchards (almonds and oranges) and/or grapes within California,
Florida, and Washington. However, following registration of abamectinthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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use expanded throughout the Southeastern United States and into
Texas, increasing to approximately 40,000–50,000 lb per year from
2006–2009 (US EPA, 2005; US Geological Survey, 2011). By 2011, the
use of abamectin nearly doubled to approximately 100,000 lb per year
due to increased penetration of the cotton market and approval as a
nematicide seed treatment on corn throughout the United States (US
EPA, 2011; US Geological Survey, 2011).
Abamectin is highly lipophilic, adsorbs strongly to soil surfaces, and
undergoes rapid photolysis, all ofwhich limit themobility and transport
of abamectin from treated agricultural ﬁelds into surface water and
groundwater (Wislocki et al., 1989). To our knowledge, abamectin
concentrations have not been monitored within dietary (food and
drinking water) sources of human exposure, likely because of very
low foliar application rates (b0.025 lb active ingredient/A) as well as
minimal transport and persistence in the environment. Based on
exposure estimates using the Dietary Exposure Evaluation Model
(DEEM), the US Environmental Protection Agency (EPA) recently
concluded that, for the general United States population, dietary
(food and drinking water) exposures to abamectin are below the
level of concern for acute and chronic risk using rat-based no-
observable adverse effect levels (NOAELs) derived from acute
(adult) neurotoxicity (NOAEL = 0.5 mg/kg/day) and developmental
neurotoxicity (NOAEL = 0.12 mg/kg/day) studies, respectively (US
EPA, 2013). Interestingly, although adult behavior was the most sensi-
tive endpoint affected within both acute and sub-chronic neurotoxicity
studies, pup body weight – rather than pup behavior – during post-
natal development was the most sensitive endpoint affected within
the developmental neurotoxicity study (US EPA, 2013). Therefore, as
prenatal development is not monitored and pups are not directly
dosed within a developmental neurotoxicity study, these data suggest
that the neurotoxic effects of abamectin in utero (if any)were reversible
following delivery. However, to our knowledge no studies have investi-
gated the potential for abamectin-induced neurotoxicity during verte-
brate embryonic development and whether these effects (if any) are
reversible following elimination of abamectin exposure.
Based on a high-content screen, we previously demonstrated
that exposure of zebraﬁsh embryos to abamectin from 5–25 hours
post-fertilization (hpf) abolished spontaneous activity – an indica-
tor of developmental neurotoxicity – in the absence of effects on
survival and gross morphology (Raftery et al., 2014). Therefore,
as zebraﬁsh is a well-established model for early vertebrate
neurodevelopment, the overall objective of this study was to begin
investigating the mechanism of abamectin-induced hypoactivity.
To accomplish this objective, we conducted experiments to (1) iden-
tify developmental stages susceptible to abamectin exposure within
the ﬁrst 24 h of embryogenesis (which is roughly equivalent to the
ﬁrst 16 days of prenatal rat development); (2) determine whether
abamectin-induced effects on spontaneous activity are reversible;
and (3) identify potential molecular initiating events responsible
for abamectin-induced hypoactivity.2. Materials and methods
2.1. Animals
Adult ﬂi1:egfp or wildtype (5D) zebraﬁsh were raised and main-
tained on a 14-h:10-h light:dark cycle within an Aquatic Habitats
Five-Shelf Stand-Alone recirculating system containing photoperiod
enclosures and conditioned reverse osmosis (RO) water (~27–28 °C).
Adult females and males were bred directly on-system using in-tank
breeding traps suspended within 3-L tanks. For all experiments
described below, newly fertilized eggs were staged according to previ-
ously described methods (Kimmel et al., 1995). All ﬁsh were handled
and treated in accordance with approved Institutional Animal Careand Use Committee (IACUC) protocols at the University of South
Carolina— Columbia.
2.2. Chemicals
Abamectin, ﬁpronil, and endosulfan were purchased from
ChemService, Inc. (West Chester, PA). Stock solutions of each
chemical were prepared by dissolving chemicals in high perfor-
mance liquid chromatography (HPLC)-grade dimethyl sulfoxide
(DMSO) (50 mM), and then performing two-fold serial dilutions
into DMSO to create stock solutions for each working solution. All
stock solutions were stored at room temperature within 2-mL
amber glass vials containing polytetraﬂuoroethylene (PTFE)-lined
caps. For each individual exposure, working solutions of all treat-
ments were freshly prepared by spiking stock solutions into embryo
media (EM) (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM
MgSO4), resulting in 0.1% DMSO within all vehicle control and
treatment groups.
2.3. Embryonic abamectin exposures
Newly fertilized eggs were collected immediately after spawning
and placed in groups of approximately 100 per petri dish within a
light- and temperature-controlled incubator until 5 hpf. Prior to
each experiment, 50-mL glass beakers were thoroughly rinsed with
DMSO and RO water. For initial screening assays, viable ﬂi1:egfp
embryos were exposed to vehicle (0.1% DMSO) or abamectin
(0.0625–0.5 μM) in triplicate glass beakers (20 per replicate beaker)
under static conditions at 28 °C from 5–24 hpf. At 24 hpf, all beakers
were removed from the incubator and allowed to acclimate at 25 °C
within treatment solution for 1 h before imaging. At 25 hpf, all
embryos within each treatment beaker were videoed for 10 s under
transmitted light using an OlympusMVX10MacroView stereomicro-
scope equipped with an Olympus DP72 Digital Color Camera and
Olympus DP2-BSW Imaging Software. Videos were analyzed manu-
ally to assess percent spontaneous activity within each beaker. Inac-
tive embryos were deﬁned as embryos that were immobile during
the entire 10-s video (152 frames), and were assigned an activity
value of 0. Embryos that moved for at least one out of 152 frames
were considered active and assigned an activity value of 1. Based
on these values, percent spontaneous activity was then calculated
for each beaker.
To identify developmental windows susceptible to abamectin expo-
sure within the ﬁrst 24 h of zebraﬁsh embryogenesis, ﬂi1:egfp embryos
were exposed to vehicle (0.1% DMSO) or 0.5 μM abamectin in triplicate
glass beakers (20 per replicate beaker) using the following static expo-
sure scenarios: (1) 5–25 hpf; (2) 10–25 hpf; and (3) 23–25 hpf. After
beakers were removed from the incubator, embryos were acclimated
at 25 °Cwithin treatment solution from24–25 hpf prior to video record-
ing under transmitted light, and spontaneous activity was analyzed as
described above. To determine whether abamectin-induced effects on
spontaneous activitywere reversible, ﬂi1:egfp embryoswereﬁrst placed
in triplicate glass beakers (20 per replicate beaker) containing EM only
at 28 °C from 5–23 hpf. Embryos were then exposed to vehicle
(0.1%DMSO)or 0.5 μMabamectin from23–27hpf at room temperature,
rinsed twice, andmaintained in clean glass beakers containing clean EM
only at room temperature until 31 hpf. Although previous studies have
concluded that spontaneous activity occurs between approximately 19
and 29 hpf (Saint-Amant and Drapeau, 1998), we have found that, at
28 °C, activity within vehicle control embryos continues beyond
31 hpf, enabling the measurement of activity for a 4-h recovery period.
A “baseline” video was recorded for each beaker before treatment solu-
tions were added, and subsequent videos were recorded every 15 min
under transmitted light. Although we did not use a FITC ﬁlter cube for
imaging, we used ﬂi1:egfp embryos to be consistent with our previous
study (Raftery et al., 2014) and, while not expected, eliminate any
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of spontaneous activity. Percent spontaneous activity was then
determined for each beaker at each time point as described above.
2.4. In situ assessment of primary motoneuron morphology within 25-hpf
zebraﬁsh embryos
Wildtype (5D) embryos were exposed in triplicate glass beakers to
either vehicle (0.1% DMSO) or 0.5 μM abamectin from 5–25 hpf at
28 °C. Live embryos were then dechorionated by incubating embryos
in 0.5 mg/mL pronase for 20 min on a shaker at 100 rpm. Embryos
were thenwashed in ROwater and ﬁxed overnight in 4% paraformalde-
hyde. Fixed embryos were permeabilized by incubating in cold acetone
at−20 °C for 15min, and then rinsed four times in phosphate-buffered
saline (PBS)/0.1% Tween-20 (PBST) for 5 min per wash. Permeabilized
embryos were incubated in fresh blocking buffer (PBST/2% sheep
serum/2 mg/mL bovine serum albumin) for 4 h at room temperature
with gentle agitation, and then incubated overnight at 4 °C with gentle
agitation in blocking buffer containing a 1:20 dilution of znp-1 IgG2a
supernatant (DSHB, University of Iowa). znp-1 IgG2a is a zebraﬁsh-
speciﬁc antibody that recognizes cell bodies and axons of primarymoto-
neurons in 25-hpf zebraﬁsh (Pike et al., 1992; Trevarrow et al., 1990).
Following primary antibody incubation, embryos were washed ﬁve
times with gentle agitation in PBST at room temperature for 15 min
each. Embryos were incubated overnight at 4 °C with gentle agitation
in blocking buffer containing a 1:500 dilution of Alexa Fluor 488
(AF488)-conjugated goat anti-mouse IgG2a (Invitrogen) to visualize
znp-1 localization in situ. Finally, secondary antibody-labeled embryos
were washed ﬁve times with gentle agitation in PBST at room tempera-
ture for 15 min each, and then stored in PBS at 4 °C until imaging.
Labeled embryos were imaged at 10× magniﬁcation using a FITC ﬁlter
cube and Olympus BX51 Research System Microscope equipped with
anOlympus DP72 Digital Color Camera andOlympusDP2-BSW Imaging
Software.
2.5. Embryonic exposures with GABA receptor antagonists
We used ﬁpronil and endosulfan – two insecticides that antagonize
the GABA receptor – to test whether abamectin-induced hypoactivity
was mediated through the GABA receptor. To identify the maximum
tolerated concentration that did not adversely impact spontaneous
activity, range-ﬁnding exposures for ﬁpronil (3.125–25 μM) and
endosulfan (0.625–5 μM) alone were ﬁrst conducted under static
exposure conditions in 50-mL beakers as described above. Based on
these range-ﬁnding exposures, the ﬁnal no-effect concentration used
for these experiments was 12.5 μM and 1.25 μM for ﬁpronil and
endosulfan, respectively. First, three replicate beakers of ﬂi1:egfp
embryos (20 per replicate beaker) were pretreated with vehicle
(0.1% DMSO), 12.5 μM ﬁpronil, or 1.25 μM endosulfan from 5–23 hpf
at 28 °C. Embryos were then washed twice with clean EM and exposed
to vehicle (0.1% DMSO) or 0.5 μM abamectin in clean beakers from
23–25 hpf. After a 1 h acclimation from24–25 hpf, videoswere recorded
and spontaneous activity was analyzed as described above.
2.6. Total RNA isolation and real-time PCR
Four replicate pools of 5-, 10-, and 23-hpf zebraﬁsh embryos
(100 individuals per pool) incubated in clean EM at 28 °C were
snap-frozen in liquid nitrogen and stored at −80 °C. Following
homogenization of embryos using a PowerGen Homogenizer (Fisher
Scientiﬁc), an SV Total RNA Isolation System (Promega) was used to
extract total RNA from pooled embryos. Prior to sample elution, total
RNA samples were on-column-digested with DNase-I to remove any
DNA contamination. Total RNA concentrations and 260/280 ratios
were determined using a Nano Drop ND-2000 spectrophotometer
and samples were stored at−80 °C.Per manufacturer's instructions, ﬁrst-strand cDNAs were generated
from total RNA samples using oligo (dT)15 primers and AMV Reverse
Transcriptase (Promega); all cDNA samples were stored at −20 °C
until use. gabra1, gabrb2, gabrg2, and 18s rRNA cDNAs were ampliﬁed
using the following primers: gabra1, forward primer 5′-GTCTGTTACG
CCTTTGTCTTCT-3′, reverse primer 5′-GCGGTGTAGGTGTTGTTCTT-3′;
gabrb2, forward primer 5′-GTGGCGGTAGGGATGAATATAG-3′, reverse
primer 5′-ACGCGGTTATCCAAGGTTAG-3′; gabrg2, forward primer 5′-
TACGGAACGCTACACTACTTTG-3′, reverse primer 5′-CCAGACATTCGT
AGCCGTATT-3′; and 18s rRNA, forward primer 5′-TCGCTAGTTGGCAT
CGTTTATG-3′, reverse primer 5′CGGAGGTTCGAAGACGATCA-3′. As 18s
rRNA is stably expressed throughout zebraﬁsh embryogenesis
(McCurley and Callard, 2008), this gene was selected as an internal
control for each developmental stage. Per manufacturer's instructions,
approximately 75 ng of cDNA for each target was PCR ampliﬁed using
GoTaq qPCR Master Mix (Promega) and an Applied Biosystems
7900HT Fast Real-Time PCR System. Real-time PCR reaction conditions
were 2 min at 95 °C followed by 45 cycles of 95 °C for 30 s, 50 °C for
30 s, and 72 °C for 15 s. Relative quantitation of gene expression within
each reaction was calculated using the comparative cycle threshold (Ct)
method as previously described (Jayasinghe and Volz, 2012).
2.7. Phylogenetic analysis
Gene and protein databases available within the National Center for
Biotechnology Information (NCBI) were searched to ﬁnd protein
sequences for all zebraﬁsh ionotropic GABA receptor (also known as
GABAAR) subunits. If protein sequences submitted to NCBI were not
available, we relied on protein sequences predicted from the most
current assembly of the zebraﬁsh genome Zv9 (http://www.ncbi.nlm.
nih.gov/genome?term=danio%20rerio). Due to minor differences in
NCBI's nomenclature for GABA receptor α4 subunit, the Basic Local
Alignment Search Tool (BLAST) was used to ﬁnd the zebraﬁsh homolog
for the human GABA receptor α4 subunit. For each zebraﬁsh GABA
receptor subunit, BLAST Link (BLink) was used to obtain the most
similar protein sequence within rat (Rattus norvegicus), mouse (Mus
musculus), and human (Homo sapiens). Multiple alignment of all protein
sequences (61 total) was conducted using EMBL-EBI's Clustal Omega
(http://www.ebi.ac.uk/Tools/msa/clustalo/), and alignment results
were imported into EMBL-EBI's ClustalW2 Phylogeny to generate a
phylogenetic tree (http://www.ebi.ac.uk/Tools/phylogeny/clustalw2_
phylogeny/).
2.8. Statistical analyses
All statistical procedures were performed using SPSS Statistics 21.0
(Chicago, IL). For analysis of all percent spontaneous activity data, a
general linear model (GLM) analysis of variance (ANOVA) (α= 0.05)
was used, as these data did not meet the equal variance assumption
for non-GLM ANOVAs. For analysis of real-time PCR data, a GLM
ANOVA (α= 0.05) was used to compare Ct values for gabra1 across
all three developmental stages. Pair-wise Tukey-based multiple
comparisons of least square means were performed to identify signiﬁ-
cant stage- or treatment-related effects.
3. Results
3.1. Abamectin abolishes spontaneous activity within early zebraﬁsh
embryos
Using a 384-well-based high-content screening assay, we previously
demonstrated that exposure of developing zebraﬁsh embryos to
≥3.125 μM abamectin – an avermectin insecticide – from 5–25 hpf
abolished spontaneous activity in the absence of effects on survival
and gross morphology (Raftery et al., 2014). Due to shifting of our
focus away from screening as well as logistical challenges associated
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all follow-up experiments within glass beakers. For this study, we ﬁrst
exposed embryos to abamectin within 50-mL glass beakers to identify
the nominal concentration that completely eliminated spontaneous ac-
tivity, as we expected this concentration to be less than the concentra-
tion within glass-bottom 384-well plates due to greater sorption of
abamectin to plastic well walls. Similar to 384-well plates, static expo-
sure of 5-hpf zebraﬁsh embryos to abamectin in glass beakers resulted
in a concentration-dependent decrease in percent spontaneous activity
at 25 hpf in the absence of effects on survival (≥85% average survival
across all concentrations tested) (Fig. 1A and B). However, complete
eliminationof spontaneous activitywasobserved at0.5 μMabamectin—
a nominal concentration approximately ~6-fold lower than the concen-
tration required to eliminate spontaneous activity within 384-well
plates (Raftery et al., 2014). Therefore, as exposure to 0.5 μM abamectin
did not result in gross abnormalities, we relied on this exposure concen-
tration for all subsequent experiments.
3.2. Abamectin does not affect neurite outgrowth of spinal motoneurons
To determine whether exposure to abamectin from 5–25 hpf
affected neurite outgrowth within zebraﬁsh embryos, we used whole-
mount immunohistochemistry to label the axons of primary motoneu-
rons in situ. Similar to ﬂi1:egfp embryos, exposure of wildtype (5D)
embryos to 0.5 μM abamectin eliminated spontaneous activity.
Although survival was ≥90% and all vehicle- and abamectin-exposed
embryos developed normally, abamectin exposure did not appear to
impact neurite outgrowth of primary motoneurons compared to
vehicle-exposed embryos (Fig. 2), suggesting that abamectin-induced
elimination of spontaneous activity was not associated with effects on
primary motoneuron development.
3.3. Abamectin induces rapid effects on spontaneous activity
To identify developmental stages susceptible to abamectin-
induced hypoactivity within the ﬁrst 25 h of zebraﬁsh embryogene-
sis, we initiated exposure of embryos to vehicle or 0.5 μM abamectin
at 5, 10, and 23 hpf and then evaluated spontaneous activity at
25 hpf. Average survival across all exposure groups was ≥95%
(Fig. 3A), and average spontaneous activity within vehicle-exposed
embryos was 83% (Fig. 3B). Surprisingly, similar to exposures initiat-
ed at 5 hpf, developing zebraﬁsh embryos were equally susceptible
to abamectin-induced hypoactivity when exposures were initiated
at 10 and 23 hpf (Fig. 3B). Given that a 2-h exposure resulted inFig. 1.Abamectin exposure from 5–25 hpf resulted in a concentration-dependent decrease in sp
taneous activity observed at 0.5 μM abamectin. (A) Survival (mean ± SD) and (B) spontane
abamectin. Numbers above each bar denote mean percent spontaneous activity. Asterisk (
(p b 0.05). N = three replicate beakers per treatment and 20 initial embryos per replicate beanearly identical effects as a 20-h exposure, these data suggest that,
rather than impacting neurodevelopment, abamectin induced rapid
neurophysiological effects within early zebraﬁsh embryos.
3.4. Abamectin-induced hypoactivity is reversible following transfer to
clean embryo media
As the effects of abamectin on spontaneous activity were rapid, we
then determined whether abamectin-induced effects on spontaneous
activity were reversible. Embryos were exposed to vehicle or 0.5 μM
abamectin from 23–27 hpf, and then transferred to clean EM until
31 hpf. Baseline (pretreatment) spontaneous activity for embryos
within beakers labeled for vehicle or abamectin exposure was 86.7
and 87.5%, respectively (Fig. 4). During the 4-h exposure period, sponta-
neous activity within vehicle-exposed embryos remained relatively
stable and ranged from 82–97% (Fig. 4). Although activity within
vehicle-exposed embryos started to decline toward the end of the 4-h
recovery period, there were no signiﬁcant differences in spontaneous
activity at all time points compared to within-vehicle baseline activity.
On the contrary, addition of abamectin resulted in a rapid decline in
spontaneous activity from 23–27 hpf (Fig. 4). Compared to within-
treatment baseline activity, a signiﬁcant decrease in percent spontane-
ous activity was observed at 24.75 hpf – only 1.75 h after initiation of
abamectin exposure – and spontaneous activity continued to decline,
reaching as low as 7.5% by the end of the 4-h exposure period (Fig. 4).
However, transfer of abamectin-exposed embryos to clean EM resulted
in a rapid increase in spontaneous activity from 27–31 hpf, with
complete recovery observed by 30.25 hpf — approximately 3.25 h
after immersion within clean EM.
3.5. Abamectin-induced hypoactivity is blocked by pretreatmentwith GABA
antagonists
To test the hypothesis that abamectin-induced hypoactivity within
zebraﬁsh embryos was mediated through reversible activation of
GABA-gated chloride channels, we pretreated zebraﬁsh embryos to
vehicle or non-toxic concentrations of ﬁpronil or endosulfan – two
insecticides that antagonize the GABA receptor – from 5–23 hpf, and
then exposed embryos to vehicle or abamectin from 23–25 hpf. Based
on initial range-ﬁnding exposureswith ﬁpronil and endosulfan, average
embryo survival across all exposure groups was ≥98% (Fig. 5A and B),
and a signiﬁcant decrease in percent spontaneous activitywas observed
at the highest concentration tested (Fig. 5C and D). Therefore, for
pretreatment experimentswith abamectin,we selected 12.5 μMﬁpronilontaneous activity in the absence of effects on survival, with complete elimination of spon-
ous activity (mean ± SD) following exposure to vehicle (0.1% DMSO) or 0.0625–0.5 μM
*) denotes signiﬁcant difference in percent spontaneous activity from vehicle control
ker.
Fig. 2. Abamectin does not affect gross primary motoneuron morphology of 25-hpf zebraﬁsh embryos. Fixed wildtype (5D) embryos exposed to vehicle (0.1% DMSO) or abamectin
(0.5 μM) from 5–25 hpf were incubated in znp-1 antibody overnight at 4 °C followed by an overnight incubation in goat anti-mouse IgG2a Alexa Fluor 488.
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based on the absence of effects on spontaneous activity (Fig. 5C and D).
In pretreatment experiments with either ﬁpronil or endosulfan,
average survival within all exposure groups was ≥90% (Fig. 6A and B).
Spontaneous activity within vehicle controls was at least 74% and, in
both cases, hypoactivity was observed within abamectin-exposed
embryos pretreatedwith vehicle (Fig. 6C andD). However, spontaneous
activity within abamectin-exposed embryos pretreated with 12.5 μM
ﬁpronil (Fig. 6C) or 1.25 μM endosulfan (Fig. 6D) ranged from 74 to
87% and was not signiﬁcantly different from vehicle-exposed embryos.
Therefore, abamectin-induced hypoactivity was blocked by pretreat-
ment with non-toxic concentrations of two GABA receptor antagonists,
suggesting that abamectin-induced hypoactivity may be mediated
through the GABA receptor.3.6. gabra1 and gabrb2 are expressed during early stages of embryonic
development
As the α1, β2, and γ2 subunits are the most prevalent ionotropic
GABA receptor subunits within the rat brain (Dawson et al., 2000;
Johnston, 1996;McKernan andWhiting, 1996;Whiting, 2003),wemea-
sured the relative levels of gabra1, gabrb2, and gabrg2 transcripts at 5,
10, and 23hpf using real-time PCR to determinewhether these subunits
were present during early development. Since gabrg2 transcripts were
non-detectable at all three stages (data not shown), we focused our
analysis on gabra1 and gabrb2, both of which were detected at 5, 10,Fig. 3. Zebraﬁsh embryos are susceptible to abamectin-induced hypoactivity following initiati
(mean ± SD) following exposure to vehicle (0.1% DMSO) from 5–25 hpf or 0.5 μM abamectin
spontaneous activity. Asterisk (*) denotes signiﬁcant difference in percent spontaneous activit
embryos per replicate beaker.and 23 hpf. Relative to gabrb2, gabra1 transcripts were ~70-fold lower
at 5 hpf but ~75- and ~17-fold higher at 10 and 23 hpf, respectively
(Fig. 7). In addition, gabra1 transcript levels were signiﬁcantly different
from one another across all three developmental stages (Fig. 7).
3.7. Ionotropic GABA receptor subunits within zebraﬁsh and mammals are
homologous
To determine whether protein sequences of zebraﬁsh and mamma-
lian ionotropic GABA receptor subunits were similar, we constructed a
phylogenetic tree to compare GABA receptor subunits across four
species: zebraﬁsh, rat, mouse, and human. As expected, phylogenetic
analysis showed that, with the exception of zebraﬁsh GABA receptor
α6 and α4 subunits, the majority of GABA receptor subunits sharing
the same letter (i.e., γ, ρ, and β) clustered into distinct clades and,
within each clade, rat, mouse, and human subunits were more similar
to each other relative to zebraﬁsh (Fig. 8). Therefore, these data indicate
that zebraﬁsh and mammalian ionotropic GABA receptor subunits are
homologous, similarities that are likely due to highly conserved and
functionally important sequence domains (e.g., ligand-binding domain)
within vertebrate ionotropic GABA receptor subunits.
4. Discussion
Using zebraﬁsh as a model, the objective of this study was to begin
investigating themechanismof abamectin-induced hypoactivity duringon of exposure at 5, 10 or 23 hpf. (A) Survival (mean ± SD) and (B) spontaneous activity
from 5–25 hpf, 10–25 hpf, or 23–25 hpf. Numbers above each bar denote mean percent
y from vehicle control (p b 0.05). N = three replicate beakers per treatment and 20 initial
Fig. 4. Immersion of abamectin-exposed embryos in clean EM results in complete recovery of spontaneous activity relative to vehicle-exposed embryos. Spontaneous activity (mean±SD)
during exposure to vehicle (0.1% DMSO) or 0.5 μMabamectin from 23–27 hpf, with subsequent recovery in clean EM from 27–31 hpf. Asterisk (*) denotes signiﬁcant difference in percent
spontaneous activity compared towithin-treatment baseline (p b 0.05). N= three replicate beakers per treatment and 20 initial embryos per replicate beaker. Baseline readingwasmea-
sured immediately prior to adding treatment solution. The dotted line indicates when embryos were rinsed and transferred to clean EM.
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following cessation of exposure. After conﬁrming that static exposure of
embryos to 0.5 μMabamectin from 5–25 hpf in glass beakers eliminated
spontaneous activity, we demonstrated that (1) abamectin did not
affect neurite outgrowth from spinal motoneurons; (2) compared
with exposure from 5–25 hpf, developing embryos were equally
susceptible to abamectin-induced hypoactivity when exposures were
initiated at 10 and 23 hpf; and (3) abamectin-induced hypoactivity
was reversible after immersion of exposed embryos in clean water.
Using ﬁpronil and endosulfan (insecticides that antagonize the GABA
receptor) as pharmacologic tools, we found that pretreatment ofFig. 5. Fipronil or endosulfan exposure from 5–25 hpf resulted in a decrease in spontaneous activ
(mean± SD) or (C, D) spontaneous activity (mean± SD) at 25 hpf following exposure to vehic
above each bar denote mean percent spontaneous activity. Asterisk (*) denotes signiﬁcant diffe
beakers per treatment and 20 initial embryos per replicate beaker.embryos with non-toxic concentrations of either antagonist from
5–23 hpf, followed by exposure to abamectin from 23–25 hpf, resulted
in spontaneous activity levels similar to embryos exposed to vehicle
alone. Finally, using quantitative PCR and phylogenetic analyses, we
then conﬁrmed the presence of GABA receptor α1 and β2 subunits in
zebraﬁsh at 5, 10, and 23 hpf, and demonstrated that zebraﬁsh
ionotropic GABA receptor subunits are homologous to mammalian
ionotropic GABA receptor subunits.
Due to the difﬁculty in assessing behavioral endpoints in utero, little
is known about the potential effects of abamectin exposure during
vertebrate embryonic development. Our results showed that, withinity at the highest concentrations tested in the absence of effects on survival. (A, B) Survival
le (0.1% DMSO), 3.125–25 μM ﬁpronil or 0.625–5 μM endosulfan from 5–25 hpf. Numbers
rence in percent spontaneous activity from vehicle control (p b 0.05). N= three replicate
Fig. 6. Abamectin-induced hypoactivity is blocked by pretreatment of embryos with non-toxic concentrations of ﬁpronil or endosulfan. (A, B) Survival (mean ± SD) and (B,
D) spontaneous activity (mean ± SD) at 25 hpf following exposure to vehicle (0.1% DMSO) or 0.5 μM abamectin (23–25 hpf) with or without ﬁpronil or endosulfan pretreatment
(5–23 hpf). Plus (+) or minus (−) signs indicate the presence or absence, respectively, of a chemical for each treatment. Numbers above each bar denote mean percent spontaneous
activity. Asterisk (*) denotes signiﬁcant difference in percent spontaneous activity from vehicle control (p b 0.05). N = three replicate beakers per treatment and 20 initial embryos
per replicate beaker.
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occurred in the absence of effects on survival and neurite outgrowth
of spinal motoneurons. However, this effect on locomotion was rapid,
as spontaneous activity within zebraﬁsh embryos decreased to nearly
7% after just 2 h of abamectin exposure (23–25 hpf), suggesting that
abamectin induces rapid, functional effects on the nervous system
rather than affecting motoneuron growth. Given that abamectin is
moderately hydrophobic (low Kow = 4.4), rapid abamectin transport
across the chorion into the embryo likely accounted for the rapidFig. 7. gabra1 and gabrb2 transcripts are present at 5, 10 and 23 hpf within normal
developing zebraﬁsh embryos. Fold change data are mean ± SD relative to gabrb2 for
each developmental stage. Developmental stages that do not share the same letter are
signiﬁcantly different (p b 0.05) from each other. N = three (10 hpf) or four (5 and
23hpf) independent samples based on extractedRNA from replicate pools of 100 embryos
per pool.decrease in spontaneous activity observed (US EPA, 2010). Similarly,
in a 14-d acute neurotoxicity study within adult rats, the most sensitive
endpoints affected after exposure to the highest abamectin concentra-
tion (6.0 mg/kg/day) by oral gavage included tiptoe gait, reduced
splay reﬂex, and, themost relevant to this study, decreasedmotor activ-
ity (US EPA, 2013). Despite rapid abamectin-induced hypoactivitywith-
in 4 h of exposure, embryos quickly recovered 3.5 h following transfer to
cleanwater, suggesting that abamectin reversibly binds to ligand-gated
chloride channels and inhibits neurotransmission. Although spontane-
ous activity within vehicle-exposed embryos slightly declined at the
end of the recovery period, this was expected due to the narrow time
window for this behavior during normal embryonic development
(Saint-Amant and Drapeau, 2000).
Interestingly, the sedative, anticonvulsant effects of abamectin
observed in zebraﬁsh and rats are similar to effects produced in mice
and humans following exposure to benzodiazepines and other
compounds that interact with the GABA receptor complex (Dawson
et al., 2000; Zanette et al., 2013). These types of compounds – including
barbituates, benzodiazepenes and ethanol – fall into a larger class of
drugs known as sedative-hypnotics, and are used to reduce tension
and anxiety, relax muscles, and/or induce sleep (Boles and Miotto,
2003). Therefore, spontaneous activity represents an integrative
behavioral readout that, combined with transparent, ex utero develop-
ment of zebraﬁsh embryos, allows for control of exposure and recovery
windows and, as such, can be used to identify compounds with an
abamectin-like mechanism of action.
Abamectin is thought to induce neurotoxicity in invertebrates and
vertebrates by activation of ligand-gated chloride channels, interfering
with signal transmission between nerve cells (Bloomquist, 1996). In
vertebrates, although both GABA and glycine receptors are selective
for chloride, previous ﬁndings demonstrate that abamectin-induced
toxicity occurs primarily through activation of GABA-gated chloride
Fig. 8. Phylogenetic analysis demonstrates that zebraﬁsh ionotropic GABA receptor (GABAAR) subunits are homologous to rodent and human ionotropic GABA receptor subunits. Multiple
alignment of all protein sequences (61 total) was conducted using EMBL-EBI's Clustal Omega, and alignment results were imported into EMBL-EBI's ClustalW2 Phylogeny to generate a
phylogenetic tree.
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that pretreatment of embryos with non-toxic concentrations of ﬁpronil
and endosulfan – two insecticides that antagonize the GABA receptor –
blocked abamectin-induced hypoactivity. Although higher concentra-
tions of both antagonists resulted in decreased spontaneous activity,
this is consistent with the paralyzing effects of GABA receptor antago-
nists at toxic concentrations due to prevention of chloride ion uptake,
leading to an overstimulation of neurons. Though ﬁpronil has been
shown to inhibit glycine receptor isoforms (Islam and Lynch, 2012),
GABA receptors have been implicated as the primary target for both
ﬁpronil and endosulfan (Cole et al., 1993; Eldefrawi and Eldefrawi,
1987). In addition, we recognize that these insecticides may have the
potential to bind other receptors within zebraﬁsh embryos; however,
initial attempts to pretreat embryos with strychnine – a rodenticide
that antagonizes the glycine receptor – failed to block the hypoactive ef-
fects of abamectin (see Supplementary material). The ability of ﬁpronil
(a phenylpyrazole insecticide) andendosulfan (a cyclodiene insecticide)–two hydrophobic compounds with distinct chemical structures – to pre-
vent abamectin-induced hypoactivity suggests that abamectin-induced
inhibition of neurotransmission within 25-hpf zebraﬁsh embryos may
be mediated through the GABA receptor.
At the time spontaneous tail contractions commence, three primary
motoneurons and seven interneurons are present within the zebraﬁsh
spinal cord (Brustein et al., 2003). As the neurotransmitter GABA is
not localized to primary motoneurons in 26-hpf zebraﬁsh (Tallafuss
and Eisen, 2008), these ﬁndings relative to our data suggest that
abamectin may act within the central nervous system, blocking signal
transmission from interneurons to excitatory motoneurons (Campbell
et al., 1983). While abamectin may inhibit neurotransmission by direct
binding to the GABA receptor or increasing endogenous GABA concen-
trations (Novelli et al., 2012), there is evidence that the GABA receptor
β subunit is a key subunit for avermectin activity (Arena et al., 1993)
and that abamectin potentiates β1- and β2-containing GABA receptors
(Dawson et al., 2000). Our quantitative PCR data demonstrate that β2
18 T.D. Raftery, D.C. Volz / Neurotoxicology and Teratology 49 (2015) 10–18andα1 GABA receptor subunits are presentwithin early-stage zebraﬁsh
embryos. Most importantly, these subunits are present at 23 hpf, the
time pointwhen addition of abamectin eliminates spontaneous activity.
Although we have not ampliﬁed additional GABA receptor subunits,
some of these subunits are likely present at 23 hpf. Although the
presence of these subunits does not conﬁrm whether abamectin elimi-
nates activity by interacting with the GABA receptor, these data do
indicate the potential for this interaction to occur. Moreover, our phylo-
genetic analyses show that zebraﬁsh and mammalian ionotropic GABA
receptor subunits are homologous, demonstrating that if abamectin is
interacting with the GABA receptor in zebraﬁsh, this ﬁnding may have
relevance to rodent models and humans.
In summary, this study resulted in threemajorﬁndings: 1) abamectin-
induced hypoactivity within zebraﬁsh embryos occurs within 2 h of ex-
posure, an effect that is reversed following transfer of abamectin-
exposed embryos to clean water; 2) abamectin-induced hypoactivity
is blocked by pretreatment with non-toxic concentrations of ﬁpronil
and endosulfan, two insecticides that antagonize the GABA receptor;
and 3) GABA receptor subunits present within the ﬁrst 24 h of zebraﬁsh
embryogenesis are homologous to mammalian GABA receptor sub-
units. While our data suggests that abamectin-induced hypoactivity
during embryonic developmentmay not result in long-term locomotive
effects, there may be a need to evaluate the potential long-term effects
of early abamectin exposure on cognition at later stages of develop-
ment. Moreover, our study supports the conclusion that spontaneous
activity represents an integrative behavioral readout that has the poten-
tial to detect GABA receptor agonists – and likely other neuroactive
chemicals – within a physiologically relevant, intact organism. There-
fore, within a tiered testing framework, early stages of embryonic
zebraﬁsh may be useful as a model for screening and prioritizing
chemicals for developmental neurotoxicity testing in mammalian
models.
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